Clinical Trials Directory

Trials / Unknown

UnknownNCT03527134

Effects of Amantadine on Postoperative Cognitive Dysfunction

Effects of Amantadine on Postoperative Cognitive Dysfunction in Elderly Patients With Elective Abdominal Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
390 (estimated)
Sponsor
Zhiyi Zuo · Academic / Other
Sex
All
Age
60 Years – 100 Years
Healthy volunteers
Accepted

Summary

Post-operative cognitive dysfunction (POCD) is a fairly well-documented clinical phenomenon. Investigators will determine whether amantadine can reduce the occurrence of POCD in elderly patients with major abdominal surgery.

Detailed description

Patients who are 60 years old or older for laparoscopic abdominal surgery will be randomly assigned into two groups: 1) no-treatment group, and 2) amantadine-treated group. Each group will have 150 patients. In addition, investigators will need 90 subjects in the control group. The data of these control subjects will be used to normalize the data of the two studied groups to diagnose POCD. The subjects in control groups will also be elderly but without the exposure to anesthesia and surgery.

Conditions

Interventions

TypeNameDescription
DRUGAmantadinepatients will receive amantadine 100 mg by month 2 h before the induction of general anesthesia and then 100 mg each time, three times per day for 5 days.

Timeline

Start date
2019-04-30
Primary completion
2021-07-01
Completion
2021-10-01
First posted
2018-05-17
Last updated
2019-01-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03527134. Inclusion in this directory is not an endorsement.